Companies: 10,795·Total market cap: $144.5T
Bausch Health Companies Inc.

Bausch Health Companies Inc.

BHCNYSEHealthcare● Active
$5.37
+$0.11(+2.09%)
Market Cap$2.0B
P/E Ratio
52W High$8.69
52W Low$4.61
Overview

Bausch Health Companies Inc. (BHC) Stock Overview

Key statistics and deep links to earnings, valuation, revenue, dividends, and more.

FMP · BHC · as of Jun 8, 2026

Key Statistics

EPS (TTM)$-3.21bhc eps ttm · bhc earnings per shareEarnings history
PE Ratio (TTM)bhc pe ratio ttm · bhc price to earningsPE Ratio deep dive
Revenue (TTM)$10.6Bbhc revenue ttm · bhc annual revenueFull revenue history
Dividend Yield4.99%does bhc pay dividends · bhc dividend yieldDividend history
Shares Outstanding370.9Mbhc shares outstanding · bhc floatShares outstanding history
Next EarningsJul 29, 2026Est.bhc earnings date · bhc next earningsEarnings history

Financial Snapshot

Full Financials
FY 2025Revenue$10.45B▲ +8.53% YoY
202320242025
bausch health companies inc. revenue · bhc revenue 2025
FY 2025Net Income$159.7M▲ +447.28% YoY
202320242025
bausch health companies inc. net income · bhc profit 2025
FY 2025EPS$0.43▲ +430.77% YoY
202320242025
bhc eps · bausch health companies inc. earnings per share 2025
TTM:Revenue: $10.55BNet Income: -$1.19BEPS: $-3.21View income statement →

Analyst Ratings & Price Target

Full Forecast
SellBuy
Buy38 analystsis bhc a buy · bhc analyst rating
Strong Buy
0
Buy
19
Hold
15
Sell
4
Strong Sell
0
12-Month Price Target
$8.00Low
$5.37Current
$8.00Avg Target48.98% upside
$8.00High
bhc price target · bhc 12 month forecast

Total: 38 · Buy rate: 50.0%

The BHC analyst consensus is Buy, based on ratings from 38 Wall Street analysts over the past 3 months. The average 12-month price target is $8.00, representing +48.98% upside from the current price of $5.37.

Stock Performance

Full History
1D+2.09%
1W+7.40%
1M-6.61%
3M-0.19%
YTD-22.73%
1Y+10.49%
5Y-82.83%

About Bausch Health Companies Inc.

CEOThomas J. Appio
IPO DateMar 29, 1994
Employees20,700
CountryCA

Bausch Health Companies Inc. together with its subsidiaries, develops, manufactures, and markets a range of pharmaceutical, medical device, and over-the-counter (OTC) products primarily in the therap…

what is bausch health companies inc. · bhc stock overview · bausch health companies inc. company profile · who is bausch health companies inc. ceo · bhc NYSE · bausch health companies inc. headquarters · bausch health companies inc. business segments

About Stock Overview & Key Data

Bausch Health Companies Inc. (BHC) is a Healthcare company in the Drug Manufacturers - Specialty & Generic industry, listed on NYSE since Mar 29, 1994. As of the latest trading session, BHC stock price is $5.37, with a market capitalization of $2.0B. The stock has returned +10.49% over the past 12 months and -22.73% year-to-date.

According to 38 Wall Street analysts, the consensus rating for Bausch Health Companies Inc. stock is Buy, with an average 12-month price target of $8.00. In fiscal year 2025, Bausch Health Companies Inc. reported revenue of $10.4B and net income of $159.7M. For detailed data — including Bausch Health Companies Inc. revenue history, earnings, dividends, and PE ratio — use the tabs above.

Frequently Asked Questions

As of the latest trading session, Bausch Health Companies Inc. (BHC) stock price is $5.37. The stock is traded on NYSE under the ticker symbol BHC. The 52-week range is $4.61 – $8.69.

BHC stock priceBHC quote todaylive ticker
Data provided by Financial Modeling PrepLast updated: Jun 8, 2026Not investment advice